BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer

with No hi ha comentaris
  • Ros, J., Baraibar, I., Sardo, E., Mulet, N., Salvà, F., Argilés, G., Tabernero, J., . . . Élez, E. (2021). BRAF, MEK and EGFR inhibition as treatment strategies in BRAF V600E metastatic colorectal cancer. Therapeutic Advances in Medical Oncology, 13. https://doi.org/10.1177/1758835921992974

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *